The Critical Role of The Piezo1/β-catenin/ATF4 Axis on The Stemness of Gli1+ BMSCs During Simulated Microgravity-Induced Bone Loss

Adv Sci (Weinh). 2023 Nov;10(32):e2303375. doi: 10.1002/advs.202303375. Epub 2023 Sep 27.

Abstract

Disuse osteoporosis is characterized by decreased bone mass caused by abnormal mechanical stimulation of bone. Piezo1 is a major mechanosensitive ion channel in bone homeostasis. However, whether intervening in the action of Piezo1 can rescue disuse osteoporosis remains unresolved. In this study, a commonly-used hindlimb-unloading model is employed to simulate microgravity. By single-cell RNA sequencing, bone marrow-derived mesenchymal stem cells (BMSCs) are the most downregulated cell cluster, and coincidentally, Piezo1 expression is mostly enriched in those cells, and is substantially downregulated by unloading. Importantly, activation of Piezo1 by systemically-introducing yoda1 mimics the effects of mechanical stimulation and thus ameliorates bone loss under simulated microgravity. Mechanistically, Piezo1 activation promotes the proliferation and osteogenic differentiation of Gli1+ BMSCs by activating the β-catenin and its target gene activating transcription factor 4 (ATF4). Inhibiting β-catenin expression substantially attenuates the effect of yoda1 on bone loss, possibly due to inhibited proliferation and osteogenic differentiation capability of Gli1+ BMSCs mediated by ATF4. Lastly, Piezo1 activation also slightly alleviates the osteoporosis of OVX and aged mice. In conclusion, impaired function of Piezo1 in BMSCs leads to insufficient bone formation especially caused by abnormal mechanical stimuli, and is thus a potential therapeutic target for osteoporosis.

Keywords: Gli1+ BMSCs; Piezo1; Wnt/β-catenin/ATF4; disuse osteoporosis; simulated microgravity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / metabolism
  • Activating Transcription Factor 4 / pharmacology
  • Animals
  • Ion Channels / pharmacology
  • Ion Channels / therapeutic use
  • Mice
  • Osteogenesis
  • Osteoporosis* / etiology
  • Weightlessness*
  • Zinc Finger Protein GLI1 / metabolism
  • Zinc Finger Protein GLI1 / pharmacology
  • Zinc Finger Protein GLI1 / therapeutic use
  • beta Catenin / genetics

Substances

  • Activating Transcription Factor 4
  • beta Catenin
  • Ion Channels
  • Piezo1 protein, mouse
  • Zinc Finger Protein GLI1
  • Atf4 protein, mouse
  • CTNNB1 protein, mouse